Stockscreener 앱 받기
44.04
0.29%
-0.13
시간 외 거래:
43.87
-0.17
-0.39%
Edgewise Therapeutics Inc 주식(EWTX)의 최신 뉴스
69,441 Shares in Edgewise Therapeutics, Inc. $EWTX Bought by Persistent Asset Partners Ltd - MarketBeat
44,466 Shares in Edgewise Therapeutics, Inc. $EWTX Bought by GSA Capital Partners LLP - MarketBeat
Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CSO Alan Russell sells $258k in stock - Investing.com
Edgewise Therapeutics CEO Kevin Koch sells $785,042 in stock - Investing.com
Edgewise Therapeutics CSO Alan Russell sells $258k in stock By Investing.com - Investing.com South Africa
Edgewise Therapeutics CMO Joanne Donovan sells $412,703 in stock - Investing.com
Edgewise Therapeutics general counsel Moore sells $219,822 in shares - Investing.com
Edgewise Therapeutics CBO sells $223k in shares for tax obligations - Investing.com
Edgewise Therapeutics general counsel Moore sells $219,822 in shares By Investing.com - Investing.com Australia
Joanne Donovan Sells 2,919 Shares of Edgewise Therapeutics (NASDAQ:EWTX) Stock - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) General Counsel Sells $219,801.12 in Stock - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) CEO Kevin Koch Sells 17,971 Shares of Stock - MarketBeat
Edgewise Therapeutics President, CEO Sold Shares Worth Over $785K - TradingView
Edgewise Therapeutics (EWTX) GC nets RSU vesting, tax sales and new grants - Stock Titan
Edgewise Therapeutics (EWTX) grants CFO 24,375 RSUs and 48,750-share option - Stock Titan
Edgewise Therapeutics (EWTX) CSO gets 97,500-share equity awards, sells shares for taxes - Stock Titan
Edgewise Therapeutics (EWTX) CEO logs RSU vesting, sell-to-cover sales and 200,000 new options - Stock Titan
Edgewise Therapeutics (EWTX) grants 50,000 RSUs and 100,000 options to CBO - Stock Titan
RA Capital’s 7.8% Edgewise Therapeutics (EWTX) stake totals 8.39M shares - Stock Titan
Paradigm BioCapital reports 9.5% stake in Edgewise Therapeutics (EWTX) common stock - Stock Titan
Edgewise Therapeutics (EWTX): Baker Bros. discloses 3.4% ownership in Schedule 13G/A - Stock Titan
Bank of America Corp DE Decreases Position in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics, Inc. SEC Filing (Aug 13, 2026) - Stock Titan
CYTK Stock Jumped To Over 2-Year Highs On HCM Trial Outcome – So, Why Are Analysts Bullish On Edgewise Therapeutics? - Stocktwits
Edgewise Therapeutics Inc (EWTX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
FMR LLC Expands Edgewise Therapeutics Inc (EWTX) Stake With 4.47 Million Share Purchase - GuruFocus
Edgewise Therapeutics, Inc. $EWTX Shares Acquired by California State Teachers Retirement System - MarketBeat
Price-Driven Insight from (EWTX) for Rule-Based Strategy - Stock Traders Daily
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Given Consensus Rating of "Moderate Buy" by Brokerages - MarketBeat
Edgewise Therapeutics Inc (EWTX) Stock News Today - TradingKey
Evercore Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $55 - Moomoo
FY2030 EPS Estimate for Edgewise Therapeutics Cut by Analyst - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Posts Earnings Results, Misses Estimates By $0.06 EPS - MarketBeat
Edgewise Therapeutics, Inc. Stock 12‑Month Price Target Raised to $50.46, Implies 12% Upside - TradingView
Edgewise ups R&D spending as pharma firm focuses on cardiovascular pipeline - bizwest.com
H.C. Wainwright Maintains Edgewise Therapeutics(EWTX.US) With Buy Rating, Maintains Target Price $45 - Moomoo
Edgewise Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
FMR LLC discloses 5.1% Edgewise Therapeutics (EWTX) holding in Schedule 13G - Stock Titan
Edgewise Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Edgewise Therapeutics Q2 net loss widens on higher expenses - TradingView
Edgewise Therapeutics Q2 Net Loss Widens to $57.3 Million - Moomoo
Edgewise Therapeutics Q2 net loss widens to $57.3 million - Quiver Quantitative
Edgewise Therapeutics reports Q2 net loss $57.3M, cash $460.7M; announces sale of sevasemten - tradingview.com
Edgewise Therapeutics 2Q 2026: Net loss $57.3M, EPS ($0.53) — 10-Q Summary - TradingView
Edgewise Therapeutics (Nasdaq: EWTX) widens loss but nets $1,550 million Sevasemten Sale - Stock Titan
BRIEF-Edgewise Therapeutics Q2 Operating Income USD -61.943 Million - TradingView
Edgewise Therapeutics Reports Second Quarter 2026 Financial Results - TradingView
Edgewise Therapeutics earnings up next after HCM data, Servier deal By Investing.com - Investing.com Australia
Edgewise Therapeutics Gains as Investors Weigh Cash-rich Reset and Cardiovascular Pipeline Progress - moomoo.com
Edgewise Therapeutics gains as investors weigh cash-rich reset and cardiovascular pipeline progress - Quiver Quantitative
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: 30% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Edgewise Therapeutics (NASDAQ:EWTX) Sees Large Volume IncreaseStill a Buy? - MarketBeat
Enterprise value to EBIT forward of Edgewise Therapeutics, Inc. – NASDAQ:EWTX - TradingView
Edgewise Therapeutics, Inc. $EWTX is Perceptive Advisors LLC's 9th Largest Position - MarketBeat
Janus Henderson Group PLC Acquires 1,348,706 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Stempoint Capital LP Sells 70,012 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
EWTX|Edgewise Therapeutics Inc|Price:41.590|Chg%:+0.750 - TradingKey
Edgewise Therapeutics Inc (EWTX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Healthcare of Ontario Pension Plan Trust Fund Sells 236,200 Shares of Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics Inc (EWTX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Edgewise Therapeutics Inc (EWTX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Edgewise Therapeutics Inc (EWTX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Edgewise Therapeutics Inc (EWTX) Balance Sheet - TradingKey
Edgewise Therapeutics Inc (EWTX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
First Light Asset Management LLC Has $31.56 Million Stake in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics, Inc. Revenue Breakdown – NASDAQ:EWTX - TradingView
1.80%
1.77%
자본화:
|
볼륨(24시간):